- Work address
-
Ottergemsesteenweg 460
9000 Gent - Maxim.Grymonprez@UGent.be
- ORCID iD
-
0000-0002-0145-6486
Show
Sort by
-
- Journal Article
- A2
- open access
Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study
-
- Journal Article
- A1
- open access
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study
-
- Journal Article
- A1
- open access
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study
-
Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis
-
Risico-batenprofiel van een standaard en een lagere dosis directe orale anticoagulantia versus warfarine bij patiënten met voorkamerfibrillatie
-
Effectiviteit en veiligheid van directe orale anticoagulantia bij patiënten met voorkamerfibrillatie
-
- Journal Article
- A1
- open access
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation : a Belgian nationwide cohort study
-
- Journal Article
- A1
- open access
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis
-
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018 : a systematic review and meta-analysis
-
- Journal Article
- A1
- open access
Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis